Effect of Antioxidant Therapy on Hepatic Fibrosis and Liver Iron Concentrations in β-Thalassemia Major Patients

Increased Oxidative Stress and Iron Overload in Jordanian β-Thalassemic Children

(2011) Maher Y. Abdalla et al.   HEMOGLOBIN

Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias

(2011) P. J. Ho et al.   INTERNAL MEDICINE JOURNAL

Hemolysis and red blood cell mechanical fragility in shed blood after total knee arthroplasty

(2011) John T. Ley et al.   TRANSFUSION

The Safety, Tolerability, and Efficacy of a Liquid Formulation of Deferiprone in Young Children With Transfusional Iron Overload

(2010) Moshen El Alfy et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Vitamin E Supplementation Reduces Oxidative Stress in Beta Thalassaemia Intermedia

(2009) W.P. Pfeifer et al.   ACTA HAEMATOLOGICA

Is the oxidative stress theory of aging dead?

(2009) Viviana I. Pérez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Vascular complications after splenectomy for hematologic disorders

(2009) S. E. Crary et al.   BLOOD

Biophysical Characterization of β-Thalassemic Red Blood Cells

(2009) Omar S. Desouky et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Reversal of liver fibrosis

(2009) MonaH Ismail et al.   Saudi Journal of Gastroenterology

Inflammation and oxidant-stress in  -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial

(2008) P. B. Walter et al.   HAEMATOLOGICA